Diasome Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Diasome Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10847
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Diasome Pharmaceuticals Inc (Diasome) is a pharmaceutical company that focusses on clinical and commercial development of therapies for diabetes and obesity. The company offers products in the fields of cell receptor targeting, insulin replacement, and hepatic (liver) glucose metabolism. Its pipeline products include multiple injected and oral formulations of liver targeted insulin’s for both type 1 and type 2 diabetic patients. Diasome’s products include injectable HDV insulin, oral HDV insulin and oral HDV + novel T2DM candidates among others. The company’s technology platform is based on the use of its proprietary Hepatocyte directed vesicle, or HDV, nanotechnology to deliver a wide range of necessary hormones and drugs to the liver. It partners with other pharmaceutical companies. Diasome is headquartered in Cleveland, Ohio, the US.

Diasome Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Diasome Pharma Raises up to USD30 Million in Venture Financing 10
Diasome Pharma Raises USD4.4 Million in Venture Financing 11
Partnerships 12
Diasome Pharma Enters into Agreement with Lyfebulb 12
Diasome Pharma Enters into Agreement with Joslin Diabetes Center 13
Licensing Agreements 14
Diasome Pharma Enters into Licensing Agreement with SDG 14
Diasome Pharmaceuticals Inc – Key Competitors 15
Diasome Pharmaceuticals Inc – Key Employees 16
Diasome Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diasome Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diasome Pharma Raises up to USD30 Million in Venture Financing 10
Diasome Pharma Raises USD4.4 Million in Venture Financing 11
Diasome Pharma Enters into Agreement with Lyfebulb 12
Diasome Pharma Enters into Agreement with Joslin Diabetes Center 13
Diasome Pharma Enters into Licensing Agreement with SDG 14
Diasome Pharmaceuticals Inc, Key Competitors 15
Diasome Pharmaceuticals Inc, Key Employees 16

List of Figures
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diasome Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Diasome Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Monash University (600079)(製薬・医療分野):企業M&A動向
    Summary Monash University (Monash) is a public university. It offers a wide range of undergraduate and postgraduate coursework programs in diverse areas of study such as business; communications and media; design, creative art, architecture; education engineering; environment and sustainability; hum …
  • Fluxion Biosciences, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Fluxion Biosciences, Inc. (Fluxion) is a pharmaceutical company that develops and provides analytical and live cell analysis tools to facilitate research discoveries and diagnostics. The company’s products include bioflux, which is used for live cell analysis under shear flow; ionflux, which …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Long Island Power Authority:企業のM&A・提携動向(エネルギー分野)
    Summary Long Island Power Authority (LIPA) is a non-profit municipal electric utility that owns retail electric transmission and distribution system. It has interests in clean solar initiative feed-in tariff projects to procure distributed solar PV generation renewable resources; solar farm projects …
  • American Caresource Holdings Inc (GNOW):企業財務及び戦略的SWOT分析
    Summary American Caresource Holdings Inc (ACS) is a healthcare service provider that offers urgent and primary care services. The center’s services include urgent care, veterans care, primary care, and occupational health services. Its urgent care services offer treatment for chest pain, abdominal p …
  • Modiin Energy Limited Partnership (MDIN.L):石油・ガス:M&Aディール及び事業提携情報
    Summary Modiin Energy Limited Partnership (Modiin Energy) is an oil and gas company that offers crude oil exploration programs. The company operates in the exploration and development of oil and natural gas properties. It owns and operates five assets such as Shimshon, Daniel east, Daniel west, Grap …
  • Amino Technologies Plc (AMO):企業概要、財務及び戦略的SWOT分析
    Summary Amino Technologies Plc (Amino Technologies) is an information technology company. The company develops and offers IPTV and hybrid/OTT innovator software technologies. Its products include IPTV products, starter kits and accessories. Amino Technologies offers IPTV products such as Timeshift, …
  • Mitchells & Butlers plc:企業のM&A・事業提携・投資動向
    Mitchells & Butlers plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitchells & Butlers plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Aerie Pharmaceuticals Inc (AERI):企業財務及び戦略的SWOT分析
    Summary Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates include Rhopressa, a once-daily eye drop which is used for the reduc …
  • TV18 Broadcast Limited (formerly IBN18 Broadcast Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TV18 Broadcast Limited (formerl …
  • Sigma-Tau Pharmaceuticals, Inc(製薬・医療分野):企業M&A動向
    Summary Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) is a research based biotechnology company that focuses on discovering and developing novel medicines to treat rare diseases. It product portfolio comprises prescription products and consumer products. Sigma-Tau’s prescription products include Adage …
  • Banco Bradesco S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Banco Bradesco S.A. Mergers and …
  • Avensia AB (AVEN):企業財務及び戦略的SWOT分析
    Summary Avensia AB (Avensia), formerly InXL innovation AB is an information technology solutions provider that offers system development services. The company provides information technology systems for e-commerce and systems development. It offers e-learning solutions such as education, authoring t …
  • Mega Corporation Ltd:企業の戦略・SWOT・財務分析
    SummaryMega Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • CGA Mining Limited (formerly Central Asia Gold Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CGA Mining Limited (formerly Ce …
  • BML Inc (4694):企業財務及び戦略的SWOT分析
    Summary BML Inc (BML) is a healthcare service provider that offers clinical testing, medical information system and genome-related businesses. The company’s services include laboratory testing, food sanitation tests, environment analysis, residual agricultural chemicals analysis, dental tests, preve …
  • Cabot Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cabot Corporation Mergers and A …
  • State Bank and Trust Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' State Bank and Trust Company Me …
  • Knusford Bhdの企業概要及び財務/SWOT分析
    Knusford Bhd Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecast …
  • AirStrip Technologies, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary AirStrip Technologies, Inc. (AirStrip) is a healthcare company that provides medical software solutions and services. The company offers mobile interoperability platform, accelerator services and wireless maternal-fetal monitoring solutions. It caters its products to healthcare providers, he …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆